#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alport's syndrome Hypereosinophilic syndrome Non-small cell lung cancer Ischaemic stroke Angiosarcoma Central nervous system neoplasm Wolfram syndrome Kearns-Sayre syndrome Ewing's sarcoma recurrent Fibrosarcoma metastatic Mantle cell lymphoma Hypersomnia Cardiomyopathy Small intestine neuroendocrine tumour Brain stem glioma More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Basic Information Primary immunodeficiency syndrome – Treatment Hairy cell leukaemia recurrent Myelodysplastic syndrome – Life with Disease Richter’s syndrome – Life with Disease Adrenogenital syndrome – Diagnostics Adrenogenital syndrome – Trials in Disease Amyotrophic lateral sclerosis – Diagnostics Congenital generalised lipodystrophy – Treatment Aicardi-Goutieres syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sxr1096 Mk-0482 Teverelix Propranolol Bi 1819479 Diacerein Cefixime Trihydrate Aflibercept A24110He Taplucainium Chloride Petosemtamab Elranatamab ZINC CHLORIDE Diroximel Fumarate Dasatinib Clomipramine Hydrochloride Tub-040 Azd5004 Damoctocog Alfa Pegol Desonide More therapies…

    Learn about Your Condition

    Blood iron increased Necrotising myositis Eye disorder Hyperadrenocorticism Acute kidney injury Endocarditis enterococcal Extra-osseous Ewing's sarcoma Metastases to biliary tract Dedifferentiated liposarcoma Ovarian granulosa cell tumour Acute promyelocytic leukaemia White matter lesion Vulval cancer Tertiary adrenal insufficiency Haemodynamic instability More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Safety and Effectiveness of Vibrio Alginolyticus Collagenase for Patients with Dupuytren’s Contracture

    Not recruiting

    1 1
    Investigated Diseases:
    • Dupuytren’s contracture
    Investigated Drugs:
    • Vibrio Alginolyticus Collagenase
    Austria Germany Italy Sweden

  • Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Mucous membrane pemphigoid
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Lactose
    • Glucose
    France

  • Study on the Effectiveness of Nintedanib and Tocilizumab for Patients with Systemic Sclerosis and Interstitial Lung Disease

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Nintedanib
    • Tocilizumab
    Poland

  • Study on the Safety and Effectiveness of EHSG-KF for Treating Deep Dermal and Full Thickness Burns in Children

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Italy The Netherlands

  • Study on Dupilumab for Treating Nummular Eczema in Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dupilumab
    Germany

  • Study on the Safety and Effectiveness of EHSG-KF for Treating Full-Thickness Skin Defects in Adults and Children

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Italy The Netherlands
Previous Page
1 … 62 63 64 65 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!